Antibody-Conjugated Quantum Dot Nanocarriers
Corresponding Organization : Yonsei University
Other organizations : Korea Institute of Radiological and Medical Sciences
Variable analysis
- Concentration of DSPE-PEG2000
- Concentration of DSPE-PEG2000-mal
- Concentration of anti-EGFR antibody (cetuximab)
- Concentration of QDs
- Concentration of doxorubicin hydrochloride
- Nanoparticle characteristics (size, surface charge, drug loading, etc.)
- Cell viability/cytotoxicity
- Incubation conditions (temperature, time, etc.)
- Cell line used
- Assay procedures (CCK-8, etc.)
- Positive control: Untreated cells
- Negative control: Cells treated with nanoparticles without anti-EGFR antibody
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!